BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 21334259)

  • 1. Development of vaccines against tuberculosis.
    Tyagi AK; Nangpal P; Satchidanandam V
    Tuberculosis (Edinb); 2011 Sep; 91(5):469-78. PubMed ID: 21334259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
    Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design of vaccines against tuberculosis directed by basic immunology.
    Reece ST; Kaufmann SH
    Int J Med Microbiol; 2008 Jan; 298(1-2):143-50. PubMed ID: 17702652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New tuberculosis vaccines.
    Martín Montañés C; Gicquel B
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.
    van Dissel JT; Soonawala D; Joosten SA; Prins C; Arend SM; Bang P; Tingskov PN; Lingnau K; Nouta J; Hoff ST; Rosenkrands I; Kromann I; Ottenhoff TH; Doherty TM; Andersen P
    Vaccine; 2011 Mar; 29(11):2100-9. PubMed ID: 21256189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides greater protective immunity against tuberculosis than the existing bacille Calmette-Guérin vaccine.
    Pinto R; Saunders BM; Camacho LR; Britton WJ; Gicquel B; Triccas JA
    J Infect Dis; 2004 Jan; 189(1):105-12. PubMed ID: 14702160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial test antigens.
    Sable SB; Plikaytis BB; Shinnick TM
    Vaccine; 2007 Feb; 25(9):1553-66. PubMed ID: 17166640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis vaccine research: the impact of immunology.
    Barker LF; Brennan MJ; Rosenstein PK; Sadoff JC
    Curr Opin Immunol; 2009 Jun; 21(3):331-8. PubMed ID: 19505813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should a new tuberculosis vaccine be administered intranasally?
    Källenius G; Pawlowski A; Brandtzaeg P; Svenson S
    Tuberculosis (Edinb); 2007 Jul; 87(4):257-66. PubMed ID: 17321797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The search for a tuberculosis vaccine: an elusive quest?
    Nagelkerke NJ; de Vlas SJ; Mahendradhata Y; Ottenhoff TH; Borgdorff M
    Tuberculosis (Edinb); 2006 Jan; 86(1):41-6. PubMed ID: 16253559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is a new tuberculosis vaccine necessary and feasible? A Cuban opinion.
    Sierra VG
    Tuberculosis (Edinb); 2006; 86(3-4):169-78. PubMed ID: 16677860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of vaccine research and development: tuberculosis.
    Girard MP; Fruth U; Kieny MP
    Vaccine; 2005 Dec; 23(50):5725-31. PubMed ID: 16153751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine approaches to prevent tuberculosis.
    Wiker HG; Mustafa T; Målen H; Riise AM
    Scand J Immunol; 2006 Sep; 64(3):243-50. PubMed ID: 16918693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells.
    Derrick SC; Yabe IM; Yang A; Morris SL
    Vaccine; 2011 Apr; 29(16):2902-9. PubMed ID: 21338678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity.
    Sable SB; Kalra M; Verma I; Khuller GK
    Clin Immunol; 2007 Mar; 122(3):239-51. PubMed ID: 17208519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New vaccines against tuberculosis.
    Mark Doherty T
    Trop Med Int Health; 2004 Jul; 9(7):818-26. PubMed ID: 15228493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rational vaccine pipeline for tuberculosis.
    Brennan MJ; Stone MR; Evans T
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1566-73. PubMed ID: 23131253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.